Exousia Pro Offers Guidance on New Subdivisions

ORLANDO, FL / ACCESS Newswire / April 17, 2025 / MARIJUANA INC. (OTCPINK:MAJI), dba Exousia Pro, a clinical-stage biotech company utilizing exosomes in the treatment of cancer and other diseases, is pleased to share guidance on the new subdivisions …
Jetzt den vollständigen Artikel lesen